Equipment

1. Are surgical robots used in your trust? Yes x2

 2. Are you currently planning to purchase a surgical robot(s) in the next 18 months? No

3. Please list the manufacturer and model of all surgical robot(s) used in your trust? Please include duplicates if multiple surgical robots of same manufacturer/model. Da Vinci XI from Intuitive and HUGO from Medtronic

4. What date was the surgical robot(s) purchased? Da Vinci XL in 2017 and HUGO in 2024

5. Are surgical robot simulators used in your trust? Yes

6. Please list the manufacturer and model of all surgical robot simulator(s) used in your trust? Please include duplicates if multiple surgical robot simulators of same manufacturer/model. Da Vinci XI Sim

7. What date was the surgical robot simulator(s) purchased? 2017

8. How many procedures were carried out with use of a surgical robot each year from 2019 to present? Please provide a breakdown by speciality. See table below.

9. How many emergency procedures were carried out with use of a surgical robot each year from 2019 to present? Please provide a breakdown by speciality.  None

10. How many consultant surgeons work within your trust, and how many of these perform robotic surgery? Please provide a breakdown by speciality. 11 consultants are trained on either the Da Vinci or HUGO

11. How much did the trust pay to purchase the surgical robot(s)? If multiple surgical robots, please specify price of each robot. Cost for both approximately £2.8m – cost per robot is exempt under section 43(2) prejudice to commercial interests.

Under Section 43(2) – prejudice to commercial interests.  Disclosure of the cost per robot is commercially sensitive information which allows suppliers to compete on a competitive market and could be damaging to suppliers regarding any future dealings and may breach contracted agreements.  Section 43(2) is a qualified exemption and is subject to the public interest test. We acknowledge the public interest in openness and transparency, but we consider there is a greater public interest in ensuring an ability to obtain best value for money, as well as withholding commercially sensitive information.  Disclosure could prejudice the Trust’s ability to obtain best quality of service and value, and may unfairly aid a competitor putting the suppliers at risk of commercial disadvantage.  We have therefore concluded that the exemption applies and that withholding the material serves the public interest better than release in this instance.

12. How much has been spent on consumables/disposables for the surgical robot(s) annually from 2019 to present? If multiple manufacturers, please provide a breakdown by manufacturer.  We are unable to provide a breakdown as the companies provide other medical devices and the cost for consumables is not broken down.

13. What is the total cost of maintenance for the robot(s) annually from 2019 to present? If multiple manufacturers, please provide a breakdown by manufacturer.  As per question 11 this data is withheld under Section 43(2) – prejudice to commercial interests.